👁 Glaucoma Meds – Topical CAIs (Carbonic Anhydrase Inhibitors)
Topical CAIs lower intraocular pressure (IOP) by
inhibiting carbonic anhydrase-2, which reduces aqueous humor production.
💊 Key CAI Eye Drops
Drug NameBrandIOP Reduction (3 mo)
Dorzolamide | Trusopt | -2.49 mmHg |
Brinzolamide | Azopt | -2.42 mmHg |
➡ Commonly used in combination therapies
⚠️ Common Side Effects
Side EffectFrequency & Notes
Bitter taste | 27%, from systemic absorption via nasolacrimal duct |
Burning sensation | 12%, generally mild |
Conjunctival hyperemia | 3%, leading cause of discontinuation |
✅ Summary
- Topical CAIs reduce aqueous production → lower IOP
- Not very potent alone, but useful in combo therapies
- Side effects are mostly local and manageable
📌 Next post: Oral CAIs and their systemic effects
Comments